Academic literature on the topic 'Immunopsychiatrie'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Immunopsychiatrie.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Immunopsychiatrie"
Pandarakalam, James Paul. "Quantum, Brain, and Immunity Triangle in Mental Health and Neurosciences." NeuroQuantology 19, no. 8 (September 4, 2021): 131–40. http://dx.doi.org/10.14704/nq.2021.19.8.nq21124.
Full textKhandaker, G. M., R. Dantzer, and P. B. Jones. "Immunopsychiatry: important facts." Psychological Medicine 47, no. 13 (April 18, 2017): 2229–37. http://dx.doi.org/10.1017/s0033291717000745.
Full textPariante, Carmine M. "Psychoneuroimmunology or immunopsychiatry?" Lancet Psychiatry 2, no. 3 (March 2015): 197–99. http://dx.doi.org/10.1016/s2215-0366(15)00042-5.
Full textKonsman, Jan. "Inflammation and Depression: A Nervous Plea for Psychiatry to Not Become Immune to Interpretation." Pharmaceuticals 12, no. 1 (February 14, 2019): 29. http://dx.doi.org/10.3390/ph12010029.
Full textBenedetti, Francesco. "Immunopsychiatry after COVID-19." Journal of Affective Disorders Reports 12 (April 2023): 100521. http://dx.doi.org/10.1016/j.jadr.2023.100521.
Full textde Abreu, Murilo S., Ana C. V. V. Giacomini, Rodrigo Zanandrea, Bruna E. dos Santos, Rafael Genario, Gabriel G. de Oliveira, Ashton J. Friend, Tamara G. Amstislavskaya, and Allan V. Kalueff. "Psychoneuroimmunology and immunopsychiatry of zebrafish." Psychoneuroendocrinology 92 (June 2018): 1–12. http://dx.doi.org/10.1016/j.psyneuen.2018.03.014.
Full textHalaris, Angelos. "WPA section's status and actual developments in psychiatric immunology/immunopsychiatry perspectives on a new era: Immunopsychiatry." Journal of Affective Disorders Reports 14 (December 2023): 100665. http://dx.doi.org/10.1016/j.jadr.2023.100665.
Full textThe Lancet Psychiatry. "Mind and antibody: the return of immunopsychiatry." Lancet Psychiatry 2, no. 3 (March 2015): 191. http://dx.doi.org/10.1016/s2215-0366(15)00057-7.
Full textMarques, Frederico Moraes Cardoso, Antônio Egídio Nardi, Antonio L. Teixeira, and Leonardo Caixeta. "Immunopsychiatry: an update on autoimmune encephalitis for neuropsychiatrists." Expert Review of Neurotherapeutics 22, no. 2 (February 1, 2022): 155–67. http://dx.doi.org/10.1080/14737175.2022.2038136.
Full textLeboyer, Marion, José Oliveira, Ryad Tamouza, and Laurent Groc. "Is it time for immunopsychiatry in psychotic disorders?" Psychopharmacology 233, no. 9 (March 18, 2016): 1651–60. http://dx.doi.org/10.1007/s00213-016-4266-1.
Full textDissertations / Theses on the topic "Immunopsychiatrie"
Ellul, Pierre. "Rôle des lymphocytes T régulateurs dans un modèle murin d'autisme induit par une activation du système immunitaire durant la gestation. Exploration de la réponse comportementale par immunomodulation de la réponse Treg par faible dose d'Interleukine-2." Electronic Thesis or Diss., Sorbonne université, 2024. https://accesdistant.sorbonne-universite.fr/login?url=https://theses-intra.sorbonne-universite.fr/2024SORUS228.pdf.
Full textImplication of regulatory T cells in autism spectrum disorder secondary to maternal immune activation during pregnancy. Rationale for the use of low-dose interleukin 2 for preventive and curative treatment.Autism spectrum disorder (ASD) is a heterogeneous clinical condition characterized by impaired social interaction and communication, and restricted and/or stereotyped behavior. Its etiopathogenesis is based on the interaction between genetic predisposition and environmental factors. Among the latter, maternal immune activation during pregnancy (MIA) increases the risk of ASD in the offspring. However, there are still many unknowns, both fundamental in animals and clinical in humans, about the mechanisms underlying the persistence of autistic symptoms. To answer these questions, we have combined an epidemiological and clinical approach, based on the cohort of ASD patients cared for at the Robert Debré Center of Excellence for Autism and Neurodevelopmental Disorders, with a fundamental approach using a mouse model of ASD in association with MIA. Our work has shown that, in mice, MIA results in a long-term defect in regulatory T cells (Tregs) in the offspring, leading to chronic inflammation of the central nervous system underlying autistic symptoms. Stimulation of Tregs with low-dose interleukin-2 normalizes autistic symptoms. In humans, we have also found this Tregs defect and described that ASD related to MIA represents a homogeneous subgroup distinct from other ASD patients. Our findings shed new light on the pathophysiology of MIA-associated ASD, which can be considered a chronic inflammatory disease of the central nervous system. Furthermore, these patients represent an identifiable subgroup within the heterogeneity of ASD, paving the way for the development of immunotherapies specifically targeting Tregs, such as the use of low-dose interleukin-2
Bennabi, Meriem. "Caractéristiques immunogénétiques et immuno-inflammatoires des troubles du spectre autistique (TSA)." Thesis, Sorbonne Paris Cité, 2017. http://www.theses.fr/2017USPCC017.
Full textAutism spectrum disorders (ASD) are severe neurodevelopmental conditions characterized by deficits in communication and social interactions, and by repetitive and stereotyped behaviors and exhibiting a constant increase in terms of prevalence. Affecting ages ranging from the early post-natal period to adulthood, ASD are clinically heterogeneous and often associated with psychiatric and somatic comorbidities underlying, in part, by immune dysfunctions. In this context, we thus focused our attention on the analysis of immunogenetic and immunological characteristics potentially implicated in the disease risk and/or in the modulation their clinical phenotype. More precisely, we evaluated the potential implication of the genetic diversity of molecules involved in innate (PRR, CLR, Dectin-1) and adaptive (HLA) immune responses in disease risk. We then analyzed the phenotypic and functional characteristics of Natural Killer cells in patients with ASD, investigating their influence on the permanent inflammatory state often reported in ASD settings.On the immunogenetic point of view, we found that the genetic diversity of Dectin-1 (CLEC7A), a candidate selected because of its involvement in the modulation of intestinal microbial disorders, was associated with Asperger syndrome, a clinical form of ASD. We observed that the CLEC7A genotype rs2078178 GG and the rs2078178 / rs16910631 GG /GG haplotype were not only more frequent in Asperger but also associated with IQ scores.In terms of HLA diversity, we identified a risk haplotype (HLA-DRB1 * 11-DQB1 * 07) and a protective haplotype (HLA-DRB1 * 17-DQB1 * 02). The risk haplotype was also found to be associated with disease’s severity as reflected by unfavorable scores in the psychiatric clinical scales tested.In the second part of this thesis, we explored the phenotypic and functional modifications of CD3-CD56 + NK cells in patients with high-functioning autism. We observed a permanent cell activation state concomitant with spontaneous degranulation capacity, sustained IFN-? production and cellular hypofunction /exhaustion after in vitro stimulation. In addition, we identified a specific cluster of NK cells, based on the HLA-DR, NKG2C, and KIR2DL1 parameters, and we observed an unexpected increase of NK NKG2C + cells in ASD subjects independent of CMV infection. Finally, we observed that the expression of KIR2DL1 and HLA-DR were respectively correlated with the scores of IQ and those evaluating the CCA-LS and SAWR scales.Taken together, these data could contribute to a better knowledge of the pathophysiological mechanisms associated with the immune system in ASD and consequently to a better categorization of the groups of patients likely to benefit from targeted immunological therapeutic strategies
Books on the topic "Immunopsychiatrie"
Teixeira, Antonio L., and Moises E. Bauer, eds. Immunopsychiatry. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190884468.001.0001.
Full textKhandaker, Golam, Neil Harrison, Edward Bullmore, and Robert Dantzer, eds. Textbook of Immunopsychiatry. Cambridge University Press, 2021. http://dx.doi.org/10.1017/9781108539623.
Full textNeil, Harrison, Robert Dantzer, Edward T. Bullmore, and Golam Khandaker. Textbook of Immunopsychiatry. University of Cambridge ESOL Examinations, 2021.
Find full textNeil, Harrison, Robert Dantzer, Edward Bullmore, and Golam Khandaker. Immunopsychiatry: An Introduction. University of Cambridge ESOL Examinations, 2021.
Find full textNeil, Harrison, Robert Dantzer, Edward Bullmore, and Golam Khandaker. Textbook of Immunopsychiatry. University of Cambridge ESOL Examinations, 2021.
Find full textTeixeira, Antonio L., and Moises E. Bauer. Immunopsychiatry: A Clinician's Introduction to the Immune Basis of Mental Disorders. Oxford University Press, Incorporated, 2019.
Find full textBook chapters on the topic "Immunopsychiatrie"
"Immunopsychiatry." In Encyclopedia of Gerontology and Population Aging, 2566. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-22009-9_301220.
Full textPavón, Lenin, Samantha Alvarez-Herrera, and Moises E. Bauer. "Overview of the Immune System." In Immunopsychiatry, 1–20. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190884468.003.0001.
Full textSilveira, Vivian Thaise da, Eduardo Candelario-Jalil, and Antonio Carlos Pinheiro de Oliveira. "Immunoneuropharmacology." In Immunopsychiatry, 21–46. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190884468.003.0002.
Full textBauer, Moises E., Natália P. Rocha, Wilson Savino, and Antonio L. Teixeira. "Immune Mechanisms Affecting the Functioning of the Central Nervous System (CNS)." In Immunopsychiatry, 47–64. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190884468.003.0003.
Full textSimões e Silva, Ana Cristina, Janaina Matos Moreira, Rafael Coelho Magalhães, and Cristian Patrick Zeni. "Immune Mechanisms and Central Nervous System (CNS) Development." In Immunopsychiatry, 65–82. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190884468.003.0004.
Full textdel Rey, Adriana, and Hugo Besedovsky. "The Immune System as a Sensor Able to Affect Other Homeostatic Systems." In Immunopsychiatry, 83–102. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190884468.003.0005.
Full textLach, Gilliard, Timothy G. Dinan, and John F. Cryan. "Microbiota-Gut-Brain Axis and Neuropsychiatric Disorders." In Immunopsychiatry, 103–26. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190884468.003.0006.
Full textTeixeira, Antonio L., Isabelle Bauer, Akif Camkurt, and Sudhakar Selvaraj. "Investigating Immune Changes in the Psychiatric Patients." In Immunopsychiatry, 127–40. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190884468.003.0007.
Full textOliveira, José, Laure Tabouy, and Marion Leboyer. "Immune Dysfunction." In Immunopsychiatry, 141–64. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190884468.003.0008.
Full textSalem, Haitham, Scott D. Lane, and Antonio L. Teixeira. "Immunology of Substance Use Disorders." In Immunopsychiatry, 165–78. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190884468.003.0009.
Full text